Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000929638-21-001215
Filing Date
2021-10-20
Accepted
2021-10-20 17:25:50
Documents
1
Group Members
JCP III SM AIV, L.P.JUGGERNAUT PARTNERS III GP, L.P.JUGGERNAUT PARTNERS III GP, LTD.METP HOLDINGS, LLCMETUCHEN THERAPEUTICS, LLC

Document Format Files

Seq Description Document Type Size
1 schedule13d.htm SC 13D/A 115882
  Complete submission text file 0000929638-21-001215.txt   117240
Mailing Address
Business Address
SHULMAN JOHN D (Filed by) CIK: 0001208886 (see all company filings)

Type: SC 13D/A

Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 973-242-0005
Petros Pharmaceuticals, Inc. (Subject) CIK: 0001815903 (see all company filings)

EIN.: 851410058 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91895 | Film No.: 211334975
SIC: 2834 Pharmaceutical Preparations